Table of Contents
<< Previous Issue | Feb 2020 (Vol: 2020, Issue: 2) | Next Issue >> |
- Section: Licensing
-
Five Prime Signs US$530 M Licensing Deal with Seattle Genetics
- Section: Mergers & Acquisitions
-
Biogen Adds Pfizer’s PF-05251749 to its Neuroscience Pipeline in US$710 M Deal
-
Assertio Sells Nucynta® Franchise to Collegium for US$375 M
- Section: Research & Development
-
Servier Expands Cellectis UCART19 Collaboration
-
GlaxoSmithKline Pays €45 M Upfront to Access Immatics’ Cell Therapy Platform